subject: Epilepsy - Drug Pipeline Analysis And Market Forecasts To 2015---aarkstore Enterprise Market [print this page] Epilepsy - Drug Pipeline Analysis and Market Forecasts to 2015
Summary
The industry analysis specialists new report, Epilepsy - Drug Pipeline Analysis and Market Forecasts to 2015 is an essential source of information and analysis on the global epilepsy market. The report identifies the key trends shaping and driving the global epilepsy market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global epilepsy sector.This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.
Scope
The scope of the report includes: I37
* Annualized global epilepsy market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
* Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France and Japan.
* Pipeline analysis data providing a split across different phases by mechanism of action being developed and emerging trends. Key classes of mechanism of action includes Voltage-gated ion channels (a2-d subunit of the voltage-gated Ca++ channel; the a subunits of voltage-gated Na+ channels; K+ channels); Enhancement of GABA-mediated transmissions, Acetylcholine agonists, NMDA targetters, Benzodiazepines.
* Analysis of the current and future market competition in the global epilepsy market. Key market players covered are Pfizer, UCB Pharma, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Abbott Laboratories, Sanofi-Aventis SA, and Cephalon.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with epilepsy.
